Compare Johnson & Johnson (JNJ) vs Remitly Global Inc (RELY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Remitly Global Inc — how do they compare? Johnson & Johnson trades at $250.14 (market cap $598.96B), while Remitly Global Inc trades at $23.83 (market cap $5.02B). The key difference: Johnson & Johnson is far larger — about 119.3× Remitly Global Inc's market cap, and Johnson & Johnson pays a 2.15% dividend while Remitly Global Inc pays none. Which is the better fit depends on your goals.
| JNJ | RELY | |
|---|---|---|
Market Cap | $598.96B | $5.02B |
Volume | 6,156,228 | — |
Sector | Health | Technology |
52-Week High | $267.24 | $25.23 |
52-Week Low | $164.36 | $12.20 |
Enterprise Value | $631.90B | $4.41B |
Dividend Yield | 2.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.
The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.
RELY trades at $23.84, down 1.2% on the day, with a bullish technical signal from moving averages and strong analyst consensus. The company shows accelerating revenue growth, reaching $1.64 billion in 2025, and achieved profitability with net income of $67.93 million. Recent news highlights expansion into the UAE market and positive earnings beats.
The outlook is positive, driven by market share gains in the remittance sector and raised 2026 guidance. Key risks include intense competition and execution challenges in international expansion. Wall Street sentiment is strongly bullish with a $27.40 price target, suggesting 15% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Remitly Global Inc
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →
